Iron is neurotoxic in retinal detachment and transferrin confers neuroprotection
Alejandra Daruich, Quentin Le Rouzic, Laurent Jonet, Marie-Christine Naud, Laura Kowalczuk, Jean-Antoine Pournaras, Jeffrey H Boatright, Aurélien Thomas, Natacha Turck, Alexandre Moulin, Francine Behar-Cohen, Emilie Picard, Alejandra Daruich, Quentin Le Rouzic, Laurent Jonet, Marie-Christine Naud, Laura Kowalczuk, Jean-Antoine Pournaras, Jeffrey H Boatright, Aurélien Thomas, Natacha Turck, Alexandre Moulin, Francine Behar-Cohen, Emilie Picard
Abstract
In retinal detachment (RD), photoreceptor death and permanent vision loss are caused by neurosensory retina separating from the retinal pigment epithelium because of subretinal fluid (SRF), and successful surgical reattachment is not predictive of total visual recovery. As retinal iron overload exacerbates cell death in retinal diseases, we assessed iron as a predictive marker and therapeutic target for RD. In the vitreous and SRF from patients with RD, we measured increased iron and transferrin (TF) saturation that is correlated with poor visual recovery. In ex vivo and in vivo RD models, iron induces immediate necrosis and delayed apoptosis. We demonstrate that TF decreases both apoptosis and necroptosis induced by RD, and using RNA sequencing, pathways mediating the neuroprotective effects of TF are identified. Since toxic iron accumulates in RD, we propose TF supplementation as an adjunctive therapy to surgery for improving the visual outcomes of patients with RD.
Figures
References
- Murakami Y., Notomi S., Hisatomi T., Nakazawa T., Ishibashi T., Miller J. W., Vavvas D. G., Photoreceptor cell death and rescue in retinal detachment and degenerations. Prog. Retin. Eye Res. 37, 114–140 (2013).
- Van de Put M. A. J., Hooymans J. M. M., Los L. I., Dutch Rhegmatogenous Retinal Detachment Study Group , The incidence of rhegmatogenous retinal detachment in The Netherlands. Ophthalmology 120, 616–622 (2013).
- Holden B. A., Fricke T. R., Wilson D. A., Jong M., Naidoo K. S., Sankaridurg P., Wong T. Y., Naduvilath T. J., Resnikoff S., Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 123, 1036–1042 (2016).
- Mitry D., Awan M. A., Borooah S., Syrogiannis A., Lim-Fat C., Campbell H., Wright A. F., Fleck B. W., Charteris D. G., Yorston D., Singh J., Long-term visual acuity and the duration of macular detachment: Findings from a prospective population-based study. Br. J. Ophthalmol. 97, 149–152 (2013).
- van de Put M. A. J., Hoeksema L., Wanders W., Nolte I. M., Hooymans J. M. M., Los L. I., Postoperative vision-related quality of life in macula-off rhegmatogenous retinal detachment patients and its relation to visual function. PLOS ONE 9, e114489 (2014).
- Anderson D. H., Stern W. H., Fisher S. K., Erickson P. A., Borgula G. A., Retinal detachment in the cat: The pigment epithelial-photoreceptor interface. Invest. Ophthalmol. Vis. Sci. 24, 906–926 (1983).
- Trichonas G., Murakami Y., Thanos A., Morizane Y., Kayama M., Debouck C. M., Hisatomi T., Miller J. W., Vavvas D. G., Receptor interacting protein kinases mediate retinal detachment-induced photoreceptor necrosis and compensate for inhibition of apoptosis. Proc. Natl. Acad. Sci. U.S.A. 107, 21695–21700 (2010).
- Lewis G. P., Guérin C. J., Anderson D. H., Matsumoto B., Fisher S. K., Rapid changes in the expression of glial cell proteins caused by experimental retinal detachment. Am. J. Ophthalmol. 118, 368–376 (1994).
- Eid R., Arab N. T. T., Greenwood M. T., Iron mediated toxicity and programmed cell death: A review and a re-examination of existing paradigms. Biochim. Biophys. Acta 1864, 399–430 (2017).
- He X., Hahn P., Iacovelli J., Wong R., King C., Bhisitkul R., Massaro-Giordano M., Dunaief J. L., Iron homeostasis and toxicity in retinal degeneration. Prog. Retin. Eye Res. 26, 649–673 (2007).
- Picard E., Fontaine I., Jonet L., Guillou F., Behar-Cohen F., Courtois Y., Jeanny J.-C., The protective role of transferrin in Müller glial cells after iron-induced toxicity. Mol. Vis. 14, 928–941 (2008).
- Picard E., Le Rouzic Q., Oudar A., Berdugo M., El Sanharawi M., Andrieu-Soler C., Naud M. C., Jonet L., Latour C., Klein C., Galiacy S., Malecaze F., Coppin H., Roth M. P., Jeanny J. C., Courtois Y., Behar-Cohen F., Targeting iron-mediated retinal degeneration by local delivery of transferrin. Free Radic. Biol. Med. 89, 1105–1121 (2015).
- Picard E., Jonet L., Sergeant C., Vesvres M.-H., Behar-Cohen F., Courtois Y., Jeanny J.-C., Overexpressed or intraperitoneally injected human transferrin prevents photoreceptor degeneration in rd10 mice. Mol. Vis. 16, 2612–2625 (2010).
- Winkler J., Hoerauf H., The retinal organ culture—a model system for the examination of the early cytoskeletal reaction pattern after retinal detachment. Klin. Monbl. Augenheilkd. 225, 269–275 (2008).
- Matsumoto H., Miller J. W., Vavvas D. G., Retinal detachment model in rodents by subretinal injection of sodium hyaluronate. J. Vis. Exp. 2013, e50660 (2013).
- Lewis G. P., Fisher S. K., Up-regulation of glial fibrillary acidic protein in response to retinal injury: Its potential role in glial remodeling and a comparison to vimentin expression. Int. Rev. Cytol. 230, 263–290 (2003).
- Miljuš G., Malenković V., Đukanović B., Kolundžić N., Nedić O., IGFBP-3/transferrin/transferrin receptor 1 complexes as principal mediators of IGFBP-3 delivery to colon cells in non-cancer and cancer tissues. Exp. Mol. Pathol. 98, 431–438 (2015).
- Cederlund M., Ghosh F., Arnér K., Andréasson S., Åkerström B., Vitreous levels of oxidative stress biomarkers and the radical-scavenger α1-microglobulin/A1M in human rhegmatogenous retinal detachment. Graefes Arch. Clin. Exp. Ophthalmol. 251, 725–732 (2013).
- Baumann B., Sterling J., Song Y., Song D., Fruttiger M., Gillies M., Shen W., Dunaief J. L., Conditional Müller cell ablation leads to retinal iron accumulation. Invest. Ophthalmol. Vis. Sci. 58, 4223–4234 (2017).
- Jeanny J. C., Picard E., Sergeant C., Jonet L., Yefimova M., Courtois Y., Iron and regulatory proteins in the normal and pathological retina. Bull. Acad. Natl. Med. 197, 661–674 (2013).
- Guajardo M. H., Terrasa A. M., Catalá A., Lipid–protein modifications during ascorbate-Fe2+ peroxidation of photoreceptor membranes: Protective effect of melatonin. J. Pineal Res. 41, 201–210 (2006).
- Devos D., Moreau C., Devedjian J. C., Kluza J., Petrault M., Laloux C., Jonneaux A., Ryckewaert G., Garçon G., Rouaix N., Duhamel A., Jissendi P., Dujardin K., Auger F., Ravasi L., Hopes L., Grolez G., Firdaus W., Sablonnière B., Strubi-Vuillaume I., Zahr N., Destée A., Corvol J. C., Pöltl D., Leist M., Rose C., Defebvre L., Marchetti P., Cabantchik Z. I., Bordet R., Targeting chelatable iron as a therapeutic modality in Parkinson’s disease. Antioxid. Redox Signal. 21, 195–210 (2014).
- Parakh N., Sharma R., Prakash O., Mahto D., Dhingra B., Sharma S., Chandra J., Neurological complications and cataract in a child with thalassemia major treated with deferiprone. J. Pediatr. Hematol. Oncol. 37, e433–e434 (2015).
- Di Nicola M., Barteselli G., Dell’Arti L., Ratiglia R., Viola F., Functional and structural abnormalities in deferoxamine retinopathy: A review of the literature. Biomed. Res. Int. 2015, 249617 (2015).
- Mobarra N., Shanaki M., Ehteram H., Nasiri H., Sahmani M., Saeidi M., Goudarzi M., Pourkarim H., Azad M., A review on iron chelators in treatment of iron overload syndromes. Int. J. Hematol. Oncol. Stem Cell Res. 10, 239–247 (2016).
- Lesnikov V. A., Lesnikova M. P., Deeg H. J., Neuroimmunomodulation and aging: A role for transferrin and the hypothalamus/thymus axis. Curr. Aging Sci. 6, 21–28 (2013).
- Sakamoto H., Sakamoto N., Oryu M., Kobayashi T., Ogawa Y., Ueno M., Shinnou M., A novel function of transferrin as a constituent of macromolecular activators of phagocytosis from platelets and their precursors. Biochem. Biophys. Res. Commun. 230, 270–274 (1997).
- Longatti A., Lamb C. A., Razi M., Yoshimura S.-i., Barr F. A., Tooze S. A., TBC1D14 regulates autophagosome formation via Rab11- and ULK1-positive recycling endosomes. J. Cell Biol. 197, 659–675 (2012).
- Johnson M. A., Firth S. M., IGFBP-3: A cell fate pivot in cancer and disease. Growth Horm. IGF Res. 24, 164–173 (2014).
- Storch S., Kübler B., Höning S., Ackmann M., Zapf J., Blum W., Braulke T., Transferrin binds insulin-like growth factors and affects binding properties of insulin-like growth factor binding protein-3. FEBS Lett. 509, 395–398 (2001).
- Baxter R. C., Nuclear actions of insulin-like growth factor binding protein-3. Gene 569, 7–13 (2015).
- Lee K.-W., Liu B., Ma L., Li H., Bang P., Koeffler H. P., Cohen P., Cellular internalization of insulin-like growth factor binding protein-3: Distinct endocytic pathways facilitate re-uptake and nuclear localization. J. Biol. Chem. 279, 469–476 (2003).
- Lauer E., Villa M., Jotterand M., Vilarino R., Bollmann M., Michaud K., Grabherr S., Augsburger M., Thomas A., Imaging mass spectrometry of elements in forensic cases by LA-ICP-MS. Int. J. Leg. Med. 131, 497–500 (2017).
- Noli L., Capalbo A., Ogilvie C., Khalaf Y., Ilic D., Discordant growth of monozygotic twins starts at the blastocyst stage: A case study. Stem Cell Rep. 5, 946–953 (2015).
- Cosgrove D., Zallocchi M., Usher protein functions in hair cells and photoreceptors. Int. J. Biochem. Cell Biol. 46, 80–89 (2014).
- Williams P. A., Braine C. E., Foxworth N. E., Cochran K. E., John S. W. M., GlyCAM1 negatively regulates monocyte entry into the optic nerve head and contributes to radiation-based protection in glaucoma. J. Neuroinflammation 14, 93 (2017).
- Gold M., Dolga A. M., Koepke J., Mengel D., Culmsee C., Dodel R., Koczulla A. R., Bach J.-P., α1-Antitrypsin modulates microglial-mediated neuroinflammation and protects microglial cells from amyloid-β-induced toxicity. J. Neuroinflammation 11, 165 (2014).
- Lee M., Li S., Sato K., Jin M., Interphotoreceptor retinoid-binding protein mitigates cellular oxidative stress and mitochondrial dysfunction induced by all-trans-retinal. Invest. Ophthalmol. Vis. Sci. 57, 1553–1562 (2016).
- Higenell V., Ruthazer E. S., Layers upon layers: MHC class I acts in the retina to influence thalamic segregation. Neuron 65, 439–441 (2010).
- Matsumoto H., Kataoka K., Tsoka P., Connor K. M., Miller J. W., Vavvas D. G., Strain difference in photoreceptor cell death after retinal detachment in mice. Invest. Ophthalmol. Vis. Sci. 55, 4165–4174 (2014).
- Elliott-Hunt C. R., Holmes F. E., Hartley D. M., Perez S., Mufson E. J., Wynick D., Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2. J. Alzheimers Dis. 25, 455–462 (2011).
- Inoue Y., Shimazawa M., Nakamura S., Imamura T., Sugitani S., Tsuruma K., Hara H., Protective effects of placental growth factor on retinal neuronal cell damage. J. Neurosci. Res. 92, 329–337 (2014).
- Coyner A. S., Ryals R. C., Ku C. A., Fischer C. M., Patel R. C., Datta S., Yang P., Wen Y., Hen R., Pennesi M. E., Retinal neuroprotective effects of flibanserin, an FDA-approved dual serotonin receptor agonist-antagonist. PLOS ONE 11, e0159776 (2016).
- Maeda A., Maeda T., Golczak M., Imanishi Y., Leahy P., Kubota R., Palczewski K., Effects of potent inhibitors of the retinoid cycle on visual function and photoreceptor protection from light damage in mice. Mol. Pharmacol. 70, 1220–1229 (2006).
Source: PubMed